Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
221.89
+1.14 (+0.52%)
Official Closing Price
Updated: 7:00 PM EST, Jan 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,426,859
Open
221.00
Bid (Size)
221.72 (100)
Ask (Size)
221.99 (1,300)
Prev. Close
220.75
Today's Range
217.00 - 223.34
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
2.96%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AbbVie Seeks To Grow Obesity Drug Portfolio — Retail Touts Drugmaker As Big Competition To Lilly
↗
January 14, 2026
Via
Stocktwits
Nasdaq, S&P 500 Futures Edge Lower Ahead Of CPI, JPMorgan Earnings: Why MSFT, NVDA, ABBV, ABAT Are Also On Traders' Radar Today
↗
January 13, 2026
Retail sentiment remained mixed on Stocktwits, with a neutral view on SPY but growing bullishness around QQQ.
Via
Stocktwits
Topics
Artificial Intelligence
Credit Cards
ETFs
Performance
YTD
-3.2%
-3.2%
1 Month
-2.4%
-2.4%
3 Month
-1.9%
-1.9%
6 Month
+16.4%
+16.4%
1 Year
+26.4%
+26.4%
More News
Read More
Revolution Medicines Dismisses Merck, Abbvie Buyout Talks While Analyst Say It Is Worth More Than $32B
↗
January 12, 2026
Via
Stocktwits
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
3 No-Brainer Dividend Stocks to Buy Right Now
↗
January 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
This ETF Is Proof That the Healthcare Rebound Is Real
↗
January 11, 2026
Via
MarketBeat
Topics
ETFs
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
January 09, 2026
Via
MarketMinute
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio
↗
January 09, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Lawsuit
MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation
January 09, 2026
Via
MarketMinute
Topics
Intellectual Property
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
January 08, 2026
Via
MarketMinute
Topics
Intellectual Property
1 Unpopular Stock That Deserves a Second Chance and 2 We Question
January 07, 2026
Via
StockStory
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating
↗
January 07, 2026
Via
MarketBeat
Revolution Medicines Stock Soars On Report Of AbbVie Takeover
↗
January 07, 2026
Via
Stocktwits
Red Spruce Capital Nets $3.7 Million by Dumping One-Third of BSCR Shares
↗
January 07, 2026
Via
The Motley Fool
Topics
Bonds
ETFs
Regulatory Compliance
3 Healthcare Stocks with Exciting Potential
January 06, 2026
Via
StockStory
Topics
Stocks
Top S&P500 movers in Monday's session
↗
January 05, 2026
Via
Chartmill
Flu Season's Here—This Dividend-Payer Controls the Shot Market
↗
January 05, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Death
Uncover the latest developments among S&P500 stocks in today's session.
↗
January 05, 2026
Via
Chartmill
26 Top Dividend Stocks to Buy and Hold in 2026
↗
January 05, 2026
Via
The Motley Fool
Topics
Intellectual Property
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment
↗
January 05, 2026
Via
Stocktwits
Take Warren Buffett's Advice: Don't Buy Any Stock in 2026 Unless It Passes This Test
↗
January 04, 2026
Via
The Motley Fool
Buying This Healthcare Stock Could Make You a Millionaire Retiree
↗
January 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
Retirement
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
January 01, 2026
Via
PredictStreet
Topics
Economy
Lawsuit
World Trade
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
The Great Rebalancing: As Consumer Confidence Falters, Investors Retreat to the Safety of Large-Cap Value
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 221.89
When was AbbVie last traded?
The last trade of AbbVie was at 01/14/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.